EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

From sequence to scaffold: Computational design of protein nanoparticle vaccines from AlphaFold2-predicted building blocks

Cyrus M Haas iD, Naveen Jasti, Annie Dosey, Joel D Allen iD, Rebecca Gillespie, Jackson McGowan, Elizabeth M Leaf iD, Max Crispin iD, Cole A DeForest iD, Masaru Kanekiyo iD, Neil P King iD

Proceedings of the National Academy of Sciences · 11.11.2025 · 122 (45)

DOI: 10.1073/pnas.2409566122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 03.11.2025. Verfasst von Cyrus M Haas und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, University of Washington, Seattle, WA 98195. Hauptthemen laut MEDLINE: Nanoparticles, Computational Biology, Vaccines. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Foundation, NIAID NIH HHS, HHS | NIH (NIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Self-assembling protein nanoparticles are being increasingly utilized in the design of next-generation vaccines due to their ability to induce antibody responses of superior magnitude, breadth, and durability. Computational protein design offers a route to nanoparticle scaffolds with structural and biochemical features tailored to specific vaccine applications. Although strategies for designing self-assembling proteins have been established, the recent development of powerful machine learning (ML)–based tools for protein structure prediction and design provides an opportunity to overcome several of their limitations. Here, we leveraged these tools to develop a generalizable method for designing self-assembling proteins starting from AlphaFold2 predictions of oligomeric protein building blocks. We used the method to generate six 60-subunit protein nanoparticles with icosahedral symmetry, and single-particle cryoelectron microscopy reconstructions of three of them revealed that they were designed with atomic-level accuracy. To transform one of these nanoparticles into a functional immunogen, we reoriented its termini through circular permutation, added a genetically encoded oligomannose-type glycan, and displayed a stabilized trimeric variant of the influenza hemagglutinin receptor-binding domain through a rigid de novo linker. The resultant immunogen elicited potent receptor-blocking and neutralizing antibody responses in mice. Our results demonstrate the practical utility of ML–based protein modeling tools in the design of nanoparticle vaccines. More broadly, by eliminating the requirement for experimentally determined structures of protein building blocks, our method dramatically expands the number of starting points available for designing self-assembling proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesComputational BiologyVaccinesAnimalsMiceCryoelectron MicroscopyInfluenza VaccinesModels, MolecularHemagglutinin Glycoproteins, Influenza VirusMachine LearningNanovaccines

Stichwörter der Autor:innen

influenzamachine learningnanoparticlesprotein designvaccines

Substanzen

Influenza VaccinesHemagglutinin Glycoproteins, Influenza VirusVaccinesNanovaccines

Autor:innen und Institutionen

  • Department of Chemical Engineering, University of Washington, Seattle, WA 98195.
  • Institute for Protein Design, University of Washington, Seattle, WA 98195.
  • Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98195.
  • Department of Molecular Engineering, University of Washington, Seattle, WA 98195.
  • Department of Biochemistry, University of Washington, Seattle, WA 98195.
  • School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom.

ORCID-Profile: Cyrus M Haas, Joel D Allen, Elizabeth M Leaf, Max Crispin, Cole A DeForest, Masaru Kanekiyo, Neil P King

Förderung

  • Gates Foundation
  • NIAID NIH HHS
  • HHS | NIH (NIH)
  • Bill and Melinda Gates Foundation

Zitieren

APA

Haas, C. M., Jasti, N., Dosey, A., Allen, J. D., Gillespie, R., McGowan, J., Leaf, E. M., Crispin, M., DeForest, C. A., Kanekiyo, M., & King, N. P. (2025). From sequence to scaffold: Computational design of protein nanoparticle vaccines from AlphaFold2-predicted building blocks. Proceedings of the National Academy of Sciences, 122(45). https://doi.org/10.1073/pnas.2409566122

Vancouver

Haas CM, Jasti N, Dosey A, Allen JD, Gillespie R, McGowan J, et al. From sequence to scaffold: Computational design of protein nanoparticle vaccines from AlphaFold2-predicted building blocks. Proceedings of the National Academy of Sciences. 2025;122(45). doi:10.1073/pnas.2409566122

BibTeX
@article{Haas2025,
  author = {Haas, Cyrus M and Jasti, Naveen and Dosey, Annie and Allen, Joel D and Gillespie, Rebecca and McGowan, Jackson and Leaf, Elizabeth M and Crispin, Max and DeForest, Cole A and Kanekiyo, Masaru and King, Neil P},
  title = {From sequence to scaffold: Computational design of protein nanoparticle vaccines from AlphaFold2-predicted building blocks},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {45},
  doi = {10.1073/pnas.2409566122}
}
Kostenlos starten →